Tango Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | -184.9% | – | – | – | – | |
| – | +11.7% | +24.9% | +79.3% | +50.2% | +3.5% | -8.7% | |
| – | +4.1% | +344.0% | +81.7% | +34.1% | +51.5% | -8.5% | |
| – | +21.9% | +245.0% | +48.1% | – | – | – | |
| – | +6,897.3% | -109.6% | – | – | – | – | |
| – | -39.1% | +66.1% | +318.7% | -80.2% | -50.6% | +39.0% | |
| – | -17,254.0% | +26.1% | – | +56.9% | +107.9% | -147.4% | |
| – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | – | |
| – | +635.3% | +341.8% | -99.5% | +5,002.5% | -42.2% | +366.8% | |
| – | -78.2% | +1,982.4% | -170.9% | – | -60.9% | +1,767.6% | |
| – | – | -189.0% | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.